Active-ingredient Dossier
Telmisartan
Active-ingredient Dossier for Telmisartan (angiotensin ii receptor blocker). Australian brands, products, PBS listings, PBAC outcomes — compiled by…
- Brand: ARX-TELMISARTAN/AMLODIPINE
- Brand: GenRx
- Brand: TELMISARTAN/
- Brand: TWYNSTA
- Brand: APO-TELMISARTAN
- Brand: MIZART
- Therapeutic area: Cardiology
What is
Telmisartan Telmisartan is an angiotensin II receptor blocker.
Australian brands containing
Telmisartan — GenRx — TWYNSTA — APO-TELMISARTAN — ARX-TELMISARTAN/AMLODIPINE — MIZART — Telmisartan HCTZ-WGR — TELMISARTAN SANDOZ — TELMISARTAN-WGR — TELMISARTAN/HCT SANDOZ — Teltartan
Therapeutic areas
Telmisartan is registered in cardiology (23 brands) and neurology (7 brands).
Sponsor landscape
Telmisartan is marketed by seven sponsors: Arrotex Pharmaceuticals, Alembic Pharmaceuticals, Alphapharm, GM Pharma, Boehringer Ingelheim, and Sun Pharma.
PBS and regulatory activity
The latest PBAC outcome was recorded on 1 July 2020, and the latest AusPAR on 14 February 2011. One brand has a PBAC outcome on record, and one brand has an AusPAR on record.